KYMR Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 16.01%

Insider Buying (Last 12 Months): $42,797,348.00

Insider Selling (Last 12 Months): $14,192,151.22

Kymera Therapeutics Insider Trading History Chart

Kymera Therapeutics Share Price & Price History

^$66.23

▲ +0.24 (0.36%)

As of 12/4/2025 05:00 PM ET

Days: 30 | 90 | 365

Kymera Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/29/2025	Nello Mainolfi	CEO	Sell	30,000	$60.99	$1,829,700.00	660,482
10/15/2025	Jared Gollob	Insider	Sell	59,576	$61.42	$3,659,157.92	109,992
10/13/2025	Jared Gollob	Insider	Sell	3,114	$60.00	$186,840.00	118,359
10/13/2025	Jeffrey W Albers	Director	Sell	5,000	$59.19	$295,950.00
9/17/2025	Bruce N. Jacobs	CFO	Sell	79,220	$50.00	$3,961,000.00	227,409
9/16/2025	Nello Mainolfi	CEO	Sell	30,000	$49.00	$1,470,000.00	660,482
6/30/2025	Bros. Advisors Lp Baker	Director	Buy	655,500	$44.00	$28,842,000.00	6,117,295
6/30/2025	Bvf Partners L P/Il	Director	Buy	317,167	$44.00	$13,955,348.00	2,798,795
6/3/2025	Elena Ridloff	Director	Sell	12,000	$46.10	$553,200.00
6/3/2025	Jeffrey W. Albers	Director	Sell	6,349	$49.00	$311,101.00
6/3/2025	Nello Mainolfi	CEO	Sell	30,000	$49.00	$1,470,000.00	660,482
3/3/2025	Bruce N. Jacobs	CFO	Sell	7,035	$30.45	$214,215.75	201,886
3/3/2025	Ellen Chiniara	Insider	Sell	2,241	$30.45	$68,238.45	80,085
3/3/2025	Jeremy G. Chadwick	COO	Sell	1,383	$30.45	$42,112.35	67,800
1/6/2025	Ellen Chiniara	Insider	Sell	3,129	$41.75	$130,635.75	54,826
9/17/2024	Pamela Esposito	Director	Sell	13,500	$48.28	$651,780.00
8/26/2024	Jeffrey W. Albers	Director	Sell	5,000	$49.10	$245,500.00
7/16/2024	Jared Gollob	Insider	Sell	23,145	$45.81	$1,060,272.45	95,470
7/9/2024	Bruce Booth	Director	Sell	453,960	$38.21	$17,345,811.60	723,246
6/12/2024	Bruce Booth	Director	Sell	16,740	$35.45	$593,433.00	803,792
6/7/2024	Joanna Horobin	Director	Sell	8,500	$32.99	$280,415.00
3/15/2024	Bruce Booth	Director	Sell	71,764	$40.46	$2,903,571.44	806,697
3/13/2024	Bruce Booth	Director	Sell	139,255	$42.23	$5,880,738.65	828,830
3/13/2024	Venture Fund X L.P. Atlas	Major Shareholder	Sell	115,090	$42.23	$4,860,250.70	4,676,075
3/11/2024	Bruce Booth	Director	Sell	51,184	$42.85	$2,193,234.40	881,266
3/11/2024	Venture Fund X L.P. Atlas	Major Shareholder	Sell	42,302	$42.85	$1,812,640.70	4,925,812
3/4/2024	Bruce N. Jacobs	CFO	Sell	3,934	$41.86	$164,677.24	142,351
2/21/2024	Jeffrey W. Albers	Director	Sell	4,385	$39.05	$171,234.25
2/9/2024	Jared Gollob	Insider	Sell	46,137	$35.50	$1,637,863.50	74,709
1/23/2024	Jeffrey W. Albers	Director	Sell	10,000	$30.05	$300,500.00
1/4/2024	Ellen Chiniara	Insider	Sell	3,295	$22.58	$74,401.10	34,205
11/2/2023	Bvf Partners L P/Il	Director	Buy	216,406	$11.64	$2,518,965.84	2,552,306
3/2/2023	Bruce N. Jacobs	CFO	Sell	1,370	$31.00	$42,470.00	104,568
1/11/2023	Bvf Partners L P/Il	Director	Buy	22,110	$29.89	$660,867.90	2,491,703
1/11/2023	Venture Fund X L.P. Atlas	Major Shareholder	Sell	21,683	$29.96	$649,622.68	5,045,242
12/14/2022	Bruce Booth	Director	Sell	378,966	$31.37	$11,888,163.42	918,528
12/14/2022	Venture Fund X L.P. Atlas	Major Shareholder	Sell	296,077	$31.37	$9,287,935.49	5,069,486

SEC Filings (Institutional Ownership Changes) for Kymera Therapeutics (NASDAQ:KYMR)

Institutional Buying and Selling by Quarter

Kymera Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/21/2025	CIBC Bancorp USA Inc.	5,375	$0.30M	0.0%	N/A	0.007%
11/17/2025	Woodline Partners LP	248,000	$14.04M	0.1%	-50.2%	0.345%
11/17/2025	Dark Forest Capital Management LP	31,052	$1.76M	0.1%	+19.7%	0.043%
11/17/2025	Alyeska Investment Group L.P.	615,091	$34.81M	0.1%	+1,130.2%	0.855%
11/17/2025	Verition Fund Management LLC	31,471	$1.78M	0.0%	+270.9%	0.044%
11/17/2025	Polar Capital Holdings Plc	397,041	$22.47M	0.1%	+58.8%	0.552%
11/17/2025	Millennium Management LLC	94,961	$5.38M	0.0%	+68.0%	0.132%
11/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	26,918	$1.53M	0.0%	-2.5%	0.037%
11/17/2025	Larson Financial Group LLC	777	$44K	0.0%	+81.5%	0.001%
11/17/2025	Jain Global LLC	58,480	$3.31M	0.0%	+51.1%	0.081%
11/17/2025	HighVista Strategies LLC	15,728	$0.89M	0.2%	N/A	0.022%
11/17/2025	Holocene Advisors LP	840,333	$47.56M	0.1%	N/A	1.168%
11/17/2025	Boxer Capital Management LLC	319,100	$18.06M	5.8%	-26.1%	0.444%
11/17/2025	Checkpoint Capital L.P.	61,750	$3.50M	1.2%	-42.3%	0.086%
11/17/2025	Bamco Inc. NY	7,000	$0.40M	0.0%	N/A	0.010%
11/17/2025	Bank of America Corp DE	186,254	$10.54M	0.0%	+38.0%	0.259%
11/17/2025	Braidwell LP	276,692	$15.66M	0.5%	N/A	0.385%
11/17/2025	Aquatic Capital Management LLC	15,353	$0.87M	0.0%	-9.7%	0.021%
11/17/2025	Alliancebernstein L.P.	48,769	$2.76M	0.0%	+3.7%	0.068%
11/17/2025	Ameriprise Financial Inc.	24,058	$1.36M	0.0%	+23.2%	0.033%
11/14/2025	Creative Planning	5,027	$0.29M	0.0%	N/A	0.007%
11/14/2025	Schonfeld Strategic Advisors LLC	39,746	$2.25M	0.0%	-32.5%	0.055%
11/14/2025	Deerfield Management Company L.P.	572,258	$32.39M	0.5%	-12.4%	0.795%
11/14/2025	California State Teachers Retirement System	40,699	$2.30M	0.0%	+12.1%	0.057%
11/14/2025	Zurcher Kantonalbank Zurich Cantonalbank	14,842	$0.84M	0.0%	+11.9%	0.021%
11/14/2025	UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC	863,762	$48.89M	0.0%	+5.5%	1.201%
11/14/2025	Two Sigma Investments LP	429,975	$24.34M	0.0%	+170.1%	0.598%
11/14/2025	Vident Advisory LLC	7,116	$0.40M	0.0%	-17.3%	0.010%
11/14/2025	Squarepoint Ops LLC	351,246	$19.88M	0.0%	+954.0%	0.488%
11/14/2025	Avoro Capital Advisors LLC	6,350,000	$359.41M	4.6%	-3.1%	8.826%
11/14/2025	Wellington Management Group LLP	5,195,691	$294.08M	0.1%	-3.3%	7.221%
11/14/2025	Comerica Bank	51,423	$2.91M	0.0%	+4.7%	0.071%
11/14/2025	Perbak Capital Partners LLP	7,504	$0.43M	0.1%	N/A	0.010%
11/14/2025	Glenmede Investment Management LP	4,241	$0.24M	0.0%	-14.9%	0.006%
11/13/2025	Marshall Wace LLP	359,076	$20.32M	0.0%	+33.3%	0.499%
11/13/2025	Kennedy Capital Management LLC	9,482	$0.54M	0.0%	+96.1%	0.013%
11/13/2025	Invesco Ltd.	79,807	$4.52M	0.0%	+66.7%	0.111%
11/13/2025	Sei Investments Co.	15,246	$0.86M	0.0%	+151.0%	0.021%
11/13/2025	UBS Group AG	648,718	$36.72M	0.0%	+16.3%	0.902%
11/13/2025	Atika Capital Management LLC	81,300	$4.60M	0.4%	-44.5%	0.113%
11/13/2025	BNP Paribas Financial Markets	10,647	$0.60M	0.0%	+113.7%	0.015%
11/13/2025	Franklin Resources Inc.	31,662	$1.79M	0.0%	-5.9%	0.044%
11/13/2025	Legal & General Group Plc	43,497	$2.46M	0.0%	+4.8%	0.060%
11/13/2025	Swiss National Bank	81,600	$4.62M	0.0%	+9.7%	0.113%
11/13/2025	Russell Investments Group Ltd.	18,991	$1.08M	0.0%	-28.9%	0.026%
11/13/2025	Schroder Investment Management Group	61,640	$3.61M	0.0%	-44.1%	0.086%
11/13/2025	First Trust Advisors LP	74,852	$4.24M	0.0%	N/A	0.104%
11/13/2025	Neo Ivy Capital Management	19,660	$1.11M	0.3%	-4.1%	0.027%
11/12/2025	Barclays PLC	155,144	$8.78M	0.0%	+8.4%	0.216%
11/12/2025	Dimensional Fund Advisors LP	731,420	$41.41M	0.0%	+29.8%	1.017%
11/12/2025	Legato Capital Management LLC	6,783	$0.38M	0.0%	N/A	0.009%
11/12/2025	Victory Capital Management Inc.	31,289	$1.77M	0.0%	+5.6%	0.043%
11/12/2025	Rafferty Asset Management LLC	68,295	$3.87M	0.0%	+70.2%	0.095%
11/12/2025	Handelsbanken Fonder AB	21,700	$1.23M	0.0%	+31.5%	0.030%
11/12/2025	Xponance Inc.	3,983	$0.23M	0.0%	N/A	0.006%
11/12/2025	Intech Investment Management LLC	14,711	$0.83M	0.0%	-36.0%	0.020%
11/12/2025	US Bancorp DE	1,865	$0.11M	0.0%	+9.8%	0.003%
11/10/2025	TD Asset Management Inc	209,248	$11.84M	0.0%	-10.9%	0.291%
11/10/2025	Patient Square Capital LP	92,592	$5.24M	1.4%	-33.9%	0.129%
11/10/2025	Ameritas Investment Partners Inc.	4,213	$0.24M	0.0%	-14.2%	0.006%
11/10/2025	China Universal Asset Management Co. Ltd.	22,532	$1.28M	0.1%	-2.4%	0.031%
11/7/2025	GSA Capital Partners LLP	5,137	$0.29M	0.0%	N/A	0.007%
11/7/2025	Vanguard Group Inc.	5,421,722	$306.87M	0.0%	-3.5%	7.535%
11/7/2025	JPMorgan Chase & Co.	192,699	$10.91M	0.0%	-7.2%	0.268%
11/7/2025	Shell Asset Management Co.	1,670	$95K	0.0%	-56.2%	0.002%
11/6/2025	Rhumbline Advisers	74,173	$4.20M	0.0%	+4.4%	0.104%
11/6/2025	Bryce Point Capital LLC	5,921	$0.34M	0.4%	N/A	0.008%
11/6/2025	Profund Advisors LLC	15,013	$0.85M	0.0%	+70.0%	0.021%
11/6/2025	ProShare Advisors LLC	11,169	$0.63M	0.0%	-7.1%	0.016%
11/6/2025	Candriam S.C.A.	191,639	$10.85M	0.1%	+24.4%	0.268%
11/5/2025	Bessemer Group Inc.	940	$53K	0.0%	+652.0%	0.001%
11/5/2025	Savant Capital LLC	4,748	$0.27M	0.0%	N/A	0.007%
11/4/2025	Principal Financial Group Inc.	3,858	$0.22M	0.0%	N/A	0.005%
11/3/2025	AlphaQuest LLC	6,078	$0.34M	0.0%	+19.4%	0.009%
11/3/2025	Arizona State Retirement System	12,431	$0.70M	0.0%	+9.5%	0.017%
11/3/2025	Knights of Columbus Asset Advisors LLC	18,891	$1.07M	0.1%	N/A	0.026%
11/3/2025	New York State Common Retirement Fund	24,396	$1.38M	0.0%	+67.7%	0.034%
11/3/2025	Mirae Asset Global Investments Co. Ltd.	2,764	$0.16M	0.0%	+9.9%	0.004%
11/3/2025	Federated Hermes Inc.	558,700	$31.62M	0.1%	N/A	0.781%
10/30/2025	Teacher Retirement System of Texas	10,314	$0.58M	0.0%	-1.8%	0.014%
10/30/2025	Universal Beteiligungs und Servicegesellschaft mbH	107,703	$6.10M	0.0%	+0.2%	0.151%
10/28/2025	Campbell & CO Investment Adviser LLC	4,571	$0.26M	0.0%	N/A	0.006%
10/23/2025	SG Americas Securities LLC	8,432	$0.48M	0.0%	-61.8%	0.012%
10/23/2025	KLP Kapitalforvaltning AS	9,000	$0.51M	0.0%	+16.9%	0.013%
10/21/2025	Altfest L J & Co. Inc.	5,318	$0.30M	0.0%	N/A	0.007%
10/21/2025	Moody Aldrich Partners LLC	28,910	$1.64M	0.3%	-16.9%	0.040%
10/15/2025	Harbor Capital Advisors Inc.	29,928	$1.69M	0.1%	-10.6%	0.042%
10/9/2025	Voya Investment Management LLC	36,455	$2.06M	0.0%	+22.4%	0.051%
9/4/2025	Osaic Holdings Inc.	1,089	$48K	0.0%	+18,050.0%	0.002%
8/28/2025	China Universal Asset Management Co. Ltd.	23,079	$1.01M	0.1%	+77.2%	0.032%
8/27/2025	Squarepoint Ops LLC	33,324	$1.45M	0.0%	-32.3%	0.047%
8/18/2025	Hudson Bay Capital Management LP	5,000	$0.22M	0.0%	N/A	0.007%
8/15/2025	Tower Research Capital LLC TRC	5,425	$0.24M	0.0%	+111.3%	0.008%
8/15/2025	Vident Advisory LLC	8,606	$0.38M	0.0%	N/A	0.012%
8/15/2025	Rafferty Asset Management LLC	40,138	$1.75M	0.0%	-31.9%	0.056%
8/15/2025	Oxford Asset Management LLP	4,598	$0.20M	0.1%	N/A	0.006%
8/15/2025	Octagon Capital Advisors LP	266,000	$11.61M	2.5%	N/A	0.372%
8/15/2025	Perceptive Advisors LLC	210,106	$9.17M	0.8%	N/A	0.294%
8/15/2025	Lazard Asset Management LLC	2,664	$0.12M	0.0%	N/A	0.004%
8/15/2025	Hudson Bay Capital Management LP	5,000	$0.22M	0.0%	N/A	0.007%

Data available starting January 2016

Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase II clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis; STAT3 program for the treatment of hematologic malignancies and solid tumors, as well as autoimmune diseases and fibrosis; and MDM2 program to treat hematological malignancies and solid tumors. The company develops STAT6, a Type 2 inflammation in allergic diseases; and TYK2, a treatment for inflammatory bowel disease, psoriasis, psoriatic arthritis, and lupus. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.

Today's Range

Now: $66.23

$65.24

$68.78

50 Day Range

MA: $61.27

$54.66

$69.67

52 Week Range

Now: $66.23

$19.44

$68.80

Volume

741,618 shs

Average Volume

678,646 shs

Market Capitalization

$4.77 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.28

Who are the company insiders with the largest holdings of Kymera Therapeutics?: Kymera Therapeutics' top insider shareholders include:
Bros Advisors Lp Baker (Director)
Venture Fund X LP Atlas (Major Shareholder)
Bvf Partners L P/Il (Director)
Bruce Booth (Director)
Nello Mainolfi (CEO)
Bruce N Jacobs (CFO)
Jared Gollob (Insider)
Ellen Chiniara (Insider)
Jeremy G Chadwick (COO)
Elena Ridloff (Director)
Jeffrey W Albers (Director)
Joanna Horobin (Director)
Pamela Esposito (Director)
Learn More about top insider investors at Kymera Therapeutics.
Who are the major institutional investors of Kymera Therapeutics?: Kymera Therapeutics' top institutional shareholders include:
Avoro Capital Advisors LLC — 8.83%
Vanguard Group Inc. — 7.54%
Wellington Management Group LLP — 7.22%
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC — 1.20%
Holocene Advisors LP — 1.17%
Dimensional Fund Advisors LP — 1.02%
Learn More about top institutional investors of Kymera Therapeutics stock.
Which major investors are selling Kymera Therapeutics stock?: During the previous quarter, KYMR stock was sold by these institutional investors:
Woodline Partners LP
Avoro Capital Advisors LLC
Vanguard Group Inc.
Wellington Management Group LLP
Boxer Capital Management LLC
Deerfield Management Company L.P.
Atika Capital Management LLC
Schroder Investment Management Group
Within the previous year, company insiders that have sold Kymera Therapeutics company stock include:
Bros Advisors Lp Baker (Director)
Venture Fund X LP Atlas (Major Shareholder)
Bvf Partners L P/Il (Director)
Bruce Booth (Director)
Nello Mainolfi (CEO)
Bruce N Jacobs (CFO)
Jared Gollob (Insider)
Learn More investors selling Kymera Therapeutics stock.
Which major investors are buying Kymera Therapeutics stock?: In the previous quarter, KYMR stock was purchased by institutional investors including:
Holocene Advisors LP
Alyeska Investment Group L.P.
Federated Hermes Inc.
Squarepoint Ops LLC
Braidwell LP
Two Sigma Investments LP
Dimensional Fund Advisors LP
Polar Capital Holdings Plc
Within the previous year, these company insiders have bought Kymera Therapeutics stock:
Bros Advisors Lp Baker (Director)
Venture Fund X LP Atlas (Major Shareholder)
Learn More investors buying Kymera Therapeutics stock.